Trials / Terminated
TerminatedNCT04757883
Immunological Follow-up After SARS CoV2 Vaccination in Kidney Transplant Recipients
Immunological Follow-up After COVID 19 Vaccination in Kidney Transplant Recipients
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 37 (actual)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigators goal is to assess the vaccine response of kidney transplant patients following vaccination against SARS-CoV-2. The study population will be derived from cohorts of kidney transplant patients who have been transplanted for more than 3 months and have no contraindications to vaccination. These patients will be vaccinated as part of routine care with a CoV-2 SARS vaccine licensed in France. In this cohort, the investigators wish to study the post-vaccination humoral response by assaying neutralizing antibodies against SARS CoV-2 and the specific cellular response of SARS Cov-2 by quantiferon and in vitro lymphocyte stimulation assays.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Study of the synthesis of antibodies directed against SARS | Between 5 mL and 45 mL of additional blood will be collected to study the synthesis of antibodies against CoV-2 SARS and to investigate whether specialised immune cells also show an effective response against the virus. |
Timeline
- Start date
- 2021-02-02
- Primary completion
- 2024-11-01
- Completion
- 2024-11-01
- First posted
- 2021-02-17
- Last updated
- 2025-08-19
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04757883. Inclusion in this directory is not an endorsement.